CDE Catalog

***Please contact NINDS CDE team (NINDSCDE@emmes.com) in case you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport Related Concussion or Traumatic Brain Injury as the Disease, please select a Sub-Disease as well.

NeuroRehab Comprehensive includes all CDE recommendations.

NeuroRehab General includes all CDE recommendations that are not disease specific.

All other NeuroRehab Sub-Diseases include recommendations specific to existing NINDS CDE project disorders.

Search Form

Displaying 1 - 25 of 1733
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification CRF Name Copyrighted or trademarked Disease Name Sub Disease Name
C15321 Imaging T2W brain lesion volume measurement

Total volume of all focal T2-hyperintense brain lesions

Supplemental-Highly Recommended Imaging Analysis Results - Follow Up Multiple Sclerosis Multiple Sclerosis
C15328 Imaging T2 lesion volume change measurement

Absolute or percent change in T2 lesion volume as compared to a reference scan acquired at an earlier timepoint

Supplemental-Highly Recommended Imaging Analysis Results - Follow Up Multiple Sclerosis Multiple Sclerosis
C15337 New enlarging T2 lesion count

The number of new or enlarging non-enhancing T2 lesions

Supplemental-Highly Recommended Imaging Analysis Results - Follow Up Multiple Sclerosis Multiple Sclerosis
C15378 Imaging new Gadolinium-enhancing lesion count

Number of new focal lesions that are gadolinium (Gd)-enhancing on T1-weighted brain images

Supplemental-Highly Recommended Imaging Analysis Results - Follow Up Multiple Sclerosis Multiple Sclerosis
C15647 Imaging elapsed time from injection to post-Gd T1-weighted sequence value

Delay in time from injection to start of post-gadolinium (Gd) T1-weighted sequence in minutes

Supplemental-Highly Recommended Magnetic Resonance Imaging (MRI) Multiple Sclerosis Multiple Sclerosis
C00015 Education year count

Number of years of education completed (age 5 and beyond)

Supplemental-Highly Recommended Social Status Multiple Sclerosis Multiple Sclerosis
C15403 Imaging change in brain volume value

Absolute or percent change in whole brain parenchymal volume as compared to a reference scan acquired at an earlier timepoint

Supplemental-Highly Recommended Imaging Analysis Results - Follow Up Multiple Sclerosis Multiple Sclerosis
C15405 Imaging brain volume fraction value

Ratio of whole brain parenchymal volume to total intracranial volume or other head-size normalization volume

Supplemental-Highly Recommended Imaging Analysis Results - Follow Up Multiple Sclerosis Multiple Sclerosis
C02400 Brain volumetric analysis measurement

Measured brain volume in cubic centimeters

Supplemental-Highly Recommended Imaging Analysis Results - Follow Up Multiple Sclerosis Multiple Sclerosis
C00015 Education year count

Number of years of education completed (age 5 and beyond)

Supplemental-Highly Recommended General Core Multiple Sclerosis Multiple Sclerosis
C15330 Imaging clinical visit type

The type of clinical visit coinciding with scan

Supplemental-Highly Recommended Magnetic Resonance Imaging (MRI) Multiple Sclerosis Multiple Sclerosis
C16100 Symptoms new or worsening neurologic indicator

Indicates whether the participant/subject has new neurologic symptoms or an acute worsening of preexisting neurologic symptoms

Supplemental-Highly Recommended Relapse Multiple Sclerosis Multiple Sclerosis
C15358 Imaging gadolinium administered in window indicator

The indicator for whether gadolinium was administered in the protocol window.

Supplemental-Highly Recommended Magnetic Resonance Imaging (MRI) Multiple Sclerosis Multiple Sclerosis
C52650 Woodcock Johnson III (WJ-III) ? Normative basis type

Type of normative basis as part of the Woodcock Johnson III (WJ-III) tests of achievement.

Supplemental Woodcock-Johnson III Test of Cognitive Abilities Multiple Sclerosis Multiple Sclerosis
C55814 Test of Memory and Learning, Second Edition (TOMAL-2) - Facial Memory (FM) raw score

The subject's raw score on the Facial Memory (FM) nonverbal subtest, as part of the Test of Memory and Learning, Second Edition(TOMAL-2).

Supplemental Test of Memory and Learning Revised (TOMAL-2) Multiple Sclerosis Multiple Sclerosis
C51095 Wide Range Assessment of Memory and Learning Second Edition (WRAML2) - Sound symbol trial 3 normal percentile category

Normalized percentile rank category for the raw score for sound symbol trial 3, as part of the Wide Range Assessment of Memory and Learning Second Edition (WRAML2)

Supplemental Wide Range Assessment of Memory and Learning, Second Edition (WRAML-2) Multiple Sclerosis Multiple Sclerosis
C54180 Woodcock Johnson III (WJ-III) ? Understanding directions picture 6 points count

Count of the number of correct test subject responses from picture 6 of the understanding directions test as part of the Woodcock Johnson III (WJ-III) tests of achievement.

Supplemental Woodcock-Johnson III Test of Cognitive Abilities Multiple Sclerosis Multiple Sclerosis
C16181 Breast fed duration value

The duration of time the participant/subject was breast fed

Supplemental Pediatric Developmental History Multiple Sclerosis Multiple Sclerosis
C20469 Brief Visuospatial Memory Test - Revised (BVMT-R) - Percent retained raw score

Raw score for Percent Retained portion of Brief Visuospatial Memory Test - Revised (BVMT-R)

Supplemental Brief Visuospatial Memory Test Revised (BVMT-R) Multiple Sclerosis Multiple Sclerosis
C50930 Wide Range Assessment of Memory and Learning Second Edition (WRAML2) - Story B day fishing recognition score

Score for the participant's recognition of the day the girl went fishing in Story B - Fishing Story, as part of the Wide Range Assessment of Memory and Learning Second Edition (WRAML2)

Supplemental Wide Range Assessment of Memory and Learning, Second Edition (WRAML-2) Multiple Sclerosis Multiple Sclerosis
C01550 Temperature measurement anatomic site

Anatomic site on or within the body where the temperature was measured.

Supplemental Vital Signs Multiple Sclerosis Multiple Sclerosis
C51220 Wide Range Assessment of Memory and Learning Second Edition (WRAML2) - General memory index working memory index difference value

Value of the difference between the general memory index and the working memory index, as part of the Wide Range Assessment of Memory and Learning Second Edition (WRAML2)

Supplemental Wide Range Assessment of Memory and Learning, Second Edition (WRAML-2) Multiple Sclerosis Multiple Sclerosis
C55969 California Verbal Learning Test - Second Edition (CVLT-II) - Source recognition discriminability score

Score of source recognition discriminability, as part of the California Verbal Learning Test (CVLT-II).

Supplemental California Verbal Learning Test - Second Edition (CVLT-II) Multiple Sclerosis Multiple Sclerosis
C51055 Wide Range Assessment of Memory and Learning Second Edition (WRAML2) - Story B total scaled score

Scaled score for the raw Story B total score, as part of the Wide Range Assessment of Memory and Learning Second Edition (WRAML2)

Supplemental Wide Range Assessment of Memory and Learning, Second Edition (WRAML-2) Multiple Sclerosis Multiple Sclerosis
C00712 Subscribed drug or substance illicitly used category

Category of illegal drugs, prescription, or over-the-counter drugs subscribed by the participant/subject, and used for purposes other than those for which they are meant to be used, or in large amounts

Supplemental Behavioral History Multiple Sclerosis Multiple Sclerosis
Displaying 1 - 25 of 1733

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.